天然膳食化合物作为抗阿尔茨海默病药物的遗传和表观遗传靶标

WO Castillo-Ordoñez, N Cajas-Salazar… - 中国神经再生研究 …, 2024 - sjzsyj.com.cn
… targets of some natural compounds in the prevention and treatment of AD. These compounds
may … Galantamine inhibits the AChE enzyme while also allosterically modulating nicotinic

神经系统和神经退行性疾病中细胞外囊泡的病理和治疗作用

P Izquierdo-Altarejos, V Moreno-Manzano… - 中国神经再生研究(英文 …, 2024 - sjzsyj.com.cn
… V (2024) Pathological and therapeutic effects of extracellular vesicles in neurological and …
of coronavirus pneumonia (phase I, NCT04276987) and COVID-19-associated acute …

[HTML][HTML] Design and methods of a prospective smartphone app-based study for digital phenotyping of mood and anxiety symptoms mixed with centralized and …

YW Kang, T hui Sun, GY Kim, HY Jung… - Psychiatry …, 2022 - ncbi.nlm.nih.gov
… or research center in a particular time like COVID-19 pandemic [ 22 ]. Decentralized research
… depending on the data characteristics and hypothesis. To analyze the basic clinical data …

[PDF][PDF] 公共政策研究資助計劃

S CHENG Wing Keung - cepu.gov.hk
… performed for comparing the pathological impact of cigarette treatment. An incubation without
any … Due to the COVID-19 pandemic, there were less relevant conference available and we …

[PDF][PDF] 中国药物作用靶点研究新进展(Ⅱ)

江振洲, 范书生, 刘家岐, 俞沁玮, 张陆勇 - 药学进展, 2022 - pps.cpu.edu.cn
通过检索2019—2020 年中国学者在国内外杂志上发表的关于恶性肿瘤, 心脑血管疾病, 神经退行
性疾病, 精神障碍性疾病, 自身免疫性疾病, 感染性疾病, 代谢类疾病等重大疾病治疗靶点的相关…